Similarly, AP2α overexpression is recognized as a prognostic indicator of shorter patient survival in epithelial ovarian carcinomas [38]; while strong AP2β expression showed a positive correlation with the poor prognoses of patients with lung adenocarcinomas [39]. Here, TFAP2B is linked to lung adenocarcinoma.